Key statistics
As of last trade, Philogen SpA (78Q:FRA) traded at 18.85, 18.93% above the 52 week low of 15.85 set on Sep 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.00 |
---|---|
High | 19.00 |
Low | 18.85 |
Bid | 19.10 |
Offer | 21.10 |
Previous close | 18.90 |
Average volume | 0.00 |
---|---|
Shares outstanding | 29.24m |
Free float | 10.97m |
P/E (TTM) | -- |
Market cap | 584.86m EUR |
EPS (TTM) | -0.1551 EUR |
Data delayed at least 15 minutes, as of Sep 23 2024 14:29 BST.
More ▼
Announcements
- Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
- Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities
- Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors
- Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma